Search results for: 'compression therapy market'

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

The global digital financial services industry is undergoing a structural transformation, driven by autonomous AI, embedded finance, blockchain-enabled value chain compression, and geopolitical fragmentation of payment systems. These shifts create opportunities for cost reduction, faster decision-making, and scalable platform-based growth, while in...

The U.S. Gene Therapy Market report provides timely information on the emerging gene therapy market. The report examines the overall market in terms of the primary factors driving growth and addresses the key challenges facing the market.

This Frost & Sullivan report examines leading service providers in North America that offer comprehensive Ethernet services across both retail and wholesale segments. The market continues to face declining revenue growth, driven by ongoing price compression, increased competition, market maturity, and the rising adoption of software-defined wide ar...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

The objective of this research service is to evaluate the present state of the U.S. oxygen therapy devices markets, presenting a forecast and analysis of the revenues. The forecast period is from 2006 to 2012, with a base year of 2005. The research service also identifies the key challenges, major market and technology trends, the competitive stru...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

Rising incidents of cardiac arrhythmia and the increasing demand for minimally invasive procedures boost the cardiac ablation (CA) market growth. In addition, fewer risks associated with the CA procedure make it a preference, worldwide. Global demand for CA procedures declined in 2020 and 2021 due to the COVID-19 pandemic restrictions on non-emerge...

The South African intravenous therapy devices markets research service entail an overview of the metrics defining this market. It gives insight into the key challenges, drivers, and restraints that impact this market currently as well as how these variables will impact the future market. Based on these findings, a seven year revenue forecast is don...